Trial NCT00470535

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000543406
Secondary IDs: RPCI-I-87106

Last trial update was posted on 2017-02-23

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

This study was terminated earlier due to a phase III study that showed this drug inferior to sorafenib

Limitations And Caveats

This study was terminated earlier due to a phase III study that showed this drug was not better than sorafenib

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID